Skip to main content
. 2019 Nov 26;20(23):5936. doi: 10.3390/ijms20235936

Figure 4.

Figure 4

Evolocumab or ezetimibe treatment prevented HFHC diet-induced atherosclerotic lesions in aortic valves. (A) Representative images of Oil Red O (ORO) staining. (B) Representative images of CD68 immunohistochemical staining. Arrowheads indicate CD68 immunohistochemical stained areas. (C) Quantified lesion area of Oil Red O staining. (D) Quantified CD68-positive staining area. * p < 0.05, ** p < 0.01, *** p < 0.001, compared with values in the HFHC diet model group. One-way ANOVA with Dunnett’s multiple comparisons test was performed.